Compare · MDLN vs VTAK
MDLN vs VTAK
Side-by-side comparison of Medline Inc. (MDLN) and Catheter Precision Inc. (VTAK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and VTAK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $50.91B, about 53685.9x VTAK ($948,208).
- Over the past year, MDLN is down 4.8% and VTAK is down 93.7% - MDLN leads by 88.8 points.
- VTAK has been more active in the news (5 items in the past 4 weeks vs 4 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 0 for VTAK).
PerformanceMDLN-4.83%VTAK-88.29%
2025-12-17+0.00%2026-07-24
- Company
- Medline Inc.
- Catheter Precision Inc.
- Price
- -
- -
- Market cap
- $50.91B
- $948,208
- 1M return
- +7.57%
- -77.98%
- 1Y return
- -4.83%
- -93.67%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- AMEX
- IPO
- 2025
- 2018
- News (4w)
- 4
- 5
- Recent ratings
- 25
- 0
Latest MDLN
- Medline strengthens California distribution network with new 1 million-square-foot facility in Perris
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
Latest VTAK
- Flyte Partners with Blade to Expand Vision Jet Distribution
- Catheter Precision Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- SEC Form EFFECT filed by Catheter Precision Inc.
- SEC Form 424B3 filed by Catheter Precision Inc.
- Flyte Partners with LifeVac to Equip Every Vision Jet with Life-Saving Equipment
- Flyte Announces Successful Launch of New Direct-to-Consumer Booking Platform
- Creatd Files Form S-1, Reports First Quarter 2026 Results and Updates Annual Meeting Schedule
- Flyte Partners with GSE Worldwide and PGA TOUR Professional Emiliano Grillo, Debuted at the 2026 U.S. Open
- SEC Form S-1 filed by Catheter Precision Inc.
- Volato Closes $2.2 Million PIPE Priced at $0.34 Per Share